跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,780 条关于
“mertansine DM1”
全部
1,780
临床试验
1,304
药物
265
机构
8
资讯
203
9个月前
Calcium-Activated Switch Enhances Antibody-Drug Conjugate Delivery and Potency in Cancer Treatment
去年
Dyne Therapeutics' DYNE-101 Shows Promise in DM1 Trial, FDA Grants Fast Track Designation
去年
PepGen Reports Promising Splicing Correction Results in DM1 Clinical Trial
11个月前
PepGen's DM1 Therapy Achieves Record 53.7% Splicing Correction in Phase 1 Trial
去年
Dyne Therapeutics' DYNE-101 Receives FDA Fast Track Designation for Myotonic Dystrophy Type 1
去年
Dyne Therapeutics' DYNE-101 Shows Promise for Accelerated Approval Pathway in DM1
去年
PepGen's Clinical Programs Advance for DMD and DM1 Amidst Financial Scrutiny
去年
T-DM1 Shows Limited Efficacy in Pretreated HER2-Positive Biliary Tract Cancer
去年
Arrowhead Pharmaceuticals Receives $100 Million Milestone Payment for ARO-DM1 Myotonic Dystrophy Treatment
去年
T-DM1 Shows Sustained Survival Benefit in HER2-Positive Breast Cancer
第 1 页,共 21 页
上一页
下一页